Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics

Published: Monday, October 14, 2013
Last Updated: Monday, October 14, 2013
Bookmark and Share
Frost & Sullivan: Hospitals and laboratories look for cost-effective test panels enabling simultaneous autoimmune diseases testing.

Successful autoimmune disease awareness campaigns are encouraging patients to seek clinical diagnostics even for general symptoms such as fatigue and gastrointestinal distress, spurring the global autoimmune disease diagnostics market. The rising incidence of gastrointestinal autoimmune conditions, primarily celiac disease, also promotes testing.

As a result, market revenue is estimated to reach $1.0 billion in 2018 from $712.5 million in 2012, according to the new Global Autoimmune Disease Diagnostics Market analysis from Frost & Sullivan (

The U.S. market will be the highest contributor to the growth of the global autoimmune disease diagnostics market, especially as the Patient Protection and Affordable Care Act expands health coverage to at least 19.5 million people in the country. The increase in the number of beneficiaries will lead to higher diagnostic testing of patients with autoimmune disease symptoms.

“Large advertising campaigns for relatively new autoimmune disease medications treating a wide variety of autoimmune diseases, including rheumatoid arthritis, chronic plaque psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis improved patient awareness,” said a Frost & Sullivan Healthcare research analyst. “The subsequent growth in testing volumes will prompt clinical laboratories to employ advanced autoimmune disease diagnostic tests.”

However, due to the broad range of symptoms associated with autoimmune diseases, clinicians regularly struggle to derive the correct diagnosis, compelling some physicians to question the value of autoimmune disease diagnostics. In fact, as much as 30 percent of healthy patients test positive incorrectly and undergo unnecessary therapies and procedures.

Moreover, several autoimmune disease diagnostic tests are designed for manual operation, and the shortage of skilled technicians limits uptake. Handling certain therapies such as enzyme-linked immunosorbent assay kits and indirect immunofluorescent assays (IFA) that are often designated as highly complex becomes all the more difficult. This created immense demand for automated diagnostic platforms that facilitate rapid and efficient testing.

“Test panels that enable the simultaneous use of multiple autoimmune disease diagnostics will provide the greatest value,” said the analyst. “Although the price per test may decline, escalating sale volumes will fuel market growth.”

As hospital and reference laboratories globally look to enhance productivity and cost-efficiency, consolidation is an inevitable trend. As a result, vendors must address their customers’ increasing demand for automated diagnostic platforms that enable rapid and efficient laboratory testing.

Global Autoimmune Disease Diagnostics Market is part of the Life Sciences Growth Partnership Service program, which also includes: Industry Financial Review of the U.S. In Vitro Diagnostics (IVD) and Life Science Research Tools Markets, U.S. Market for Rheumatoid Arthritis Pharmacotherapeutics, Overview of Indian In Vitro Diagnostics Market, U.S. Clinical Laboratory Market, and Western European IVD Market, among others.

All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Monday, August 24, 2015
Changing Phase of Biomarkers
Discover the current scenario and changing business models of the biomarkers field.
Monday, April 13, 2015
Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe
Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018.
Thursday, June 26, 2014
Personalized Medicine Drives Uptake of Next-generation Sequencing in Europe
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years.
Saturday, May 31, 2014
Emerging Technologies Redefine Infectious Disease Diagnostics
The largest opportunities lie in the developing regions of Asia, Africa and Latin America.
Wednesday, April 23, 2014
Live Cell Imaging Revolutionizes Disease Diagnostics and Drug Discovery
Stakeholder collaboration will be crucial to convert these developments into clinically meaningful tests.
Friday, March 21, 2014
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Offering attractive procurement strategies will boost adoption of high-end tools.
Thursday, February 06, 2014
Demand for Rapid Results, Non-invasive Methods and Automated Monitoring Driving the Global POCT Market
Frost & Sullivan finds healthcare infrastructure modernization in developing nations and expanding application scope boosts opportunities for POCT.
Monday, September 30, 2013
Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market
Participants need to focus on product customization, ease-of-use and reliability.
Monday, April 22, 2013
High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe
Companies can increase profits by offering customized testing solutions with accurate, result-oriented features.
Thursday, November 29, 2012
Analysis for Tomorrow's Clinical Approach to Diagnostics, Therapy, Intervention and Monitoring Solutions
As the diverse areas of healthcare forge ahead into overlapping mechanisms and treatments, so too must medical technologies reform to solve several challenges via streamlined remedies.
Thursday, March 22, 2012
Converging towards Integrated Healthcare: A Frost & Sullivan Think Tank on Megatrends Affecting the Healthcare Industry
A clear separation between Medical Devices, Healthcare Technologies and Life Sciences is increasingly difficult. Yet the convergence of all areas opens the door to a new era, enabling personalisation, targeted medicines, new drug delivery mechanisms, and virtual patient monitoring tools, while allowing a preventative approach to healthcare at the same time.
Friday, October 08, 2010
Theranostics Paves the Way for Personalised Medicine in Europe, Says Frost & Sullivan
Strategic Analysis of the European Markets for Theranostics finds that theranostics plays a crucial role in every step of drug development process.
Tuesday, March 23, 2010
Scientific News
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos